β-Hydroxybutyrate increases the pilocarpine-induced seizure threshold in young mice

Brain and Development

Volumn 34, Issue 3, 2012, Pages 181-184

  Yum, Mi Sun ^a   Ko, Tae Sung ^a   Kim, Dong Wook ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

(R) 3 Hydroxybutyric acid; Ketone body; Mice; Pilocarpine; Seizure

Indexed keywords

3 HYDROXYBUTYRIC ACID; ANTICONVULSIVE AGENT; PILOCARPINE; SCOPOLAMINE METHYL BROMIDE;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; MALE; MOUSE; NONHUMAN; SEIZURE; SEIZURE THRESHOLD; SINGLE DRUG DOSE;

3-HYDROXYBUTYRIC ACID; ANIMALS; ANTICONVULSANTS; CONVULSANTS; KETOGENIC DIET; KETONE BODIES; MALE; MICE; MICE, INBRED ICR; PILOCARPINE; REACTION TIME; SEIZURES;

EID: 84856975512     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2011.05.012     Document Type: Article

References (18)

1. Wheless J.W. History of the ketogenic diet. Epilepsia 2008, 49(Suppl. 8):3-5.
2. Hartman A.L., Gasior M., Vining E.P., Rogawski M.A. The neuropharmacology of the ketogenic diet. Pediatr Neurol 2007, 36:281-292.
3. Samala R., Willis S., Borges K. Anticonvulsant profile of a balanced ketogenic diet in acute mouse seizure models. Epilepsy Res 2008, 81:119-127.
4. Rho J.M., Anderson G.D., Donevan S.D., White H.S. Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 2002, 43:358-361.
5. Racine R.J. Modification of seizure activity by electrical stimulation II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972, 32:281-294.
6. Wilder R. The effect of ketonemia on the course of epilepsy. Mayo Clin Proc 1921, 2:307-308.
7. Greene A.E., Todorova M.T., Seyfried T.N. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J Neurochem 2003, 86:529-537.
8. Cahill G.F. Starvation in man. N Engl J Med 1970, 282:668-675.
9. Veech R.L., Chance B., Kashiwaya Y., Lardy H.A., Cahill G.F. Ketone bodies, potential therapeutic uses. IUBMB Life 2001, 51:241-247.
10. Kim D.W., Kim J.M. Beta-Hydroxybutyrate decreases flurothyl-induced seizure susceptibility in rats. Epilepsia 2004, 45(Suppl. 7):210.
11. Turski W.A., Cavalheiro E.A., Coimbra C., da Penha Berzaghi M., Ikonomidou-Turski C., Turski L. Only certain antiepileptic drugs prevent seizures induced by pilocarpine. Brain Research 1987, 434:281-305.
12. Guzman M., Blazquez C. Is there an astrocyte-neuron ketone body shuttle?. Trends Endocrinol Metab 2001, 12:169-173.
13. Yudkoff M., Daikhin Y., Nissim I., Lazarow A., Nissim I. Ketogenic diet, amino acid metabolism, and seizure control. J Neurosci Res 2001, 66:931-940.
14. Rho J.M., Kim D.W., Robbins C.A., Anderson G.D., Schwartzkroin P.A. Age-dependent differences in flurothyl seizure sensitivity in mice treated with a ketogenic diet. Epilepsy Res 1999, 37:233-240.
15. Mejias-Aponte C.A., Jimenez-Rivera C.A., Segarra A.C. Sex differences in models of temporal lobe epilepsy: role of testosterone. Brain Research 2002, 944:210-218.
16. Veliskova J. Estrogens and epilepsy: why are we so excited?. Neuroscientist 2007, 13:77-88.
17. Samoilova M., Weisspapir M., Abdelmalik P., Velumian A.A., Carlen P.L. Chronic in vitro ketosis is neuroprotective but not anti-convulsant. J Neurochem 2010, 113:826-835.
18. van Delft R., Lambrechts D., Verschuure P., Hulsman J., Majoie M. Blood beta-hydroxybutyrate correlates better with seizure reduction due to ketogenic diet than do ketones in the urine. Seizure 2010, 19:36-39.